Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
作者信息
Badagliacca Roberto, Sciomer Susanna, Petrosillo Nicola
机构信息
Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
出版信息
J Heart Lung Transplant. 2020 Jul;39(7):729-730. doi: 10.1016/j.healun.2020.04.007. Epub 2020 Apr 17.
Abstract
摘要
相似文献
1
Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
J Heart Lung Transplant. 2020 Jul;39(7):729-730. doi: 10.1016/j.healun.2020.04.007. Epub 2020 Apr 17.
2
COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
Hemoglobin. 2020 May;44(3):218-220. doi: 10.1080/03630269.2020.1779082. Epub 2020 Jun 18.
3
Clinical course of COVID-19 in pulmonary arterial hypertension patients.
Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):775-778. doi: 10.1016/j.rec.2020.05.015. Epub 2020 May 30.
4
Acute pulmonary embolism: An unseen villain in COVID-19.
Indian Heart J. 2020 May-Jun;72(3):218-219. doi: 10.1016/j.ihj.2020.05.003. Epub 2020 May 16.
5
Psoriasis-COVID 19 Infection: Treatment Options.
Skinmed. 2020 Mar 1;18(2):81-82. eCollection 2020.
6
Management of venous thromboembolism during the COVID-19 pandemic.
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):897-898. doi: 10.1016/j.jvsv.2020.05.005. Epub 2020 May 23.
7
"Long covid": the Dutch response.
BMJ. 2020 Aug 14;370:m3202. doi: 10.1136/bmj.m3202.
8
COVID-19 complications in children.
Br J Nurs. 2020 Nov 12;29(20):1146. doi: 10.12968/bjon.2020.29.20.1146.
9
DMCN 2020 highlights: COVID-19 and beyond.
Dev Med Child Neurol. 2020 Dec;62(12):1345. doi: 10.1111/dmcn.14674.
10
From doctors as patients: a manifesto for tackling persisting symptoms of covid-19.
BMJ. 2020 Sep 15;370:m3565. doi: 10.1136/bmj.m3565.
引用本文的文献
1
Transpulmonary Plasma Endothelin-1 Arterial:Venous Ratio Differentiates Survivors from Non-Survivors in Critically Ill Patients with COVID-19-Induced Acute Respiratory Distress Syndrome.
Int J Mol Sci. 2024 Oct 2;25(19):10640. doi: 10.3390/ijms251910640.
2
Proposed Mechanisms for the Relationship between Periodontal Diseases and the Severity of Covid-19: Common Pathogens, Inflammatory Mediators, and Risk Factors.
Adv Biomed Res. 2024 Apr 27;13:28. doi: 10.4103/abr.abr_116_23. eCollection 2024.
3
Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors.
F1000Res. 2022 Sep 12;10:792. doi: 10.12688/f1000research.53966.2. eCollection 2021.
4
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02276-2021. Print 2022 Oct.
5
Pulmonary artery targeted therapy in treatment of COVID-19 related ARDS. Literature review.
Biomed Pharmacother. 2022 Feb;146:112592. doi: 10.1016/j.biopha.2021.112592. Epub 2021 Dec 25.
6
Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19.
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211042940. doi: 10.1177/10760296211042940.
7
Cardiovascular Disease Complicating COVID-19 in the Elderly.
Medicina (Kaunas). 2021 Aug 17;57(8):833. doi: 10.3390/medicina57080833.
8
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.
EPMA J. 2021 Aug 4;12(3):265-305. doi: 10.1007/s13167-021-00248-z. eCollection 2021 Sep.
9
Lung histopathological findings in COVID-19 disease - a systematic review.
Infect Agent Cancer. 2021 May 17;16(1):34. doi: 10.1186/s13027-021-00369-0.
10
Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform.
Molecules. 2021 Mar 29;26(7):1912. doi: 10.3390/molecules26071912.
本文引用的文献
1
SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death.
Cell Death Dis. 2018 Sep 5;9(9):904. doi: 10.1038/s41419-018-0917-y.
2
Lipopolysaccharide-induced necroptosis of brain microvascular endothelial cells can be prevented by inhibition of endothelin receptors.
Physiol Res. 2018 Jun 27;67(Suppl 1):S227-S236. doi: 10.33549/physiolres.933842.
3
RIP3: a molecular switch for necrosis and inflammation.
Genes Dev. 2013 Aug 1;27(15):1640-9. doi: 10.1101/gad.223321.113.
4
Many stimuli pull the necrotic trigger, an overview.
Cell Death Differ. 2012 Jan;19(1):75-86. doi: 10.1038/cdd.2011.164. Epub 2011 Nov 11.
5
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore.
Hum Pathol. 2003 Aug;34(8):743-8. doi: 10.1016/s0046-8177(03)00367-8.
Zotero 插件